Mimics and chameleons in motor neurone disease

por Turner, Martin R, Talbot, Kevin
Publicado 2013

Sweet food preference in amyotrophic lateral sclerosis

por Turner, Martin R, Talbot, Kevin
Publicado 2017

Pathogenesis of FUS-associated ALS and FTD: insights from rodent models

por Nolan, Matthew, Talbot, Kevin, Ansorge, Olaf
Publicado 2016

The Role of Mitochondrial Dysfunction and ER Stress in TDP-43 and C9ORF72 ALS

por Dafinca, Ruxandra, Barbagallo, Paola, Talbot, Kevin
Publicado 2021

The contribution of mouse models to understanding the pathogenesis of spinal muscular atrophy

por Sleigh, James N., Gillingwater, Thomas H., Talbot, Kevin
Publicado 2011

Higher blood high density lipoprotein and apolipoprotein A1 levels are associated with reduced risk of developing amyotrophic lateral sclerosis

por Thompson, Alexander G, Talbot, Kevin, Turner, Martin R
Publicado 2022

Neurotrophic Properties of C-Terminal Domain of the Heavy Chain of Tetanus Toxin on Motor Neuron Disease

por Herrando-Grabulosa, Mireia, Casas, Caty, Talbot, Kevin, Aguilera, José
Publicado 2020

Primary care blood tests show lipid profile changes in pre-symptomatic amyotrophic lateral sclerosis

por Thompson, Alexander G, Marsden, Rachael, Talbot, Kevin, Turner, Martin R
Publicado 2023

Cerebrovascular injury as a risk factor for amyotrophic lateral sclerosis

por Turner, Martin R, Goldacre, Raph, Talbot, Kevin, Goldacre, Michael J
Publicado 2016

Psychiatric disorders prior to amyotrophic lateral sclerosis

por Turner, Martin R., Goldacre, Raph, Talbot, Kevin, Goldacre, Michael J.
Publicado 2016

Towards a TDP-43-Based Biomarker for ALS and FTLD

por Feneberg, Emily, Gray, Elizabeth, Ansorge, Olaf, Talbot, Kevin, Turner, Martin R.
Publicado 2018

A fine balance between Prpf19 and Exoc7 in achieving degradation of aggregated protein and suppression of cell death in spinocerebellar ataxia type 3

por Chen, Zhefan Stephen, Huang, Xiaoying, Talbot, Kevin, Chan, Ho Yin Edwin
Publicado 2021

The ALSFRS as an outcome measure in therapeutic trials and its relationship to symptom onset

por Proudfoot, Malcolm, Jones, Ashley, Talbot, Kevin, Al-Chalabi, Ammar, Turner, Martin R.
Publicado 2016

Amyotrophic lateral sclerosis: the complex path to precision medicine

por Talbot, Kevin, Feneberg, Emily, Scaber, Jakub, Thompson, Alexander G., Turner, Martin R.
Publicado 2018

Quantitative FLAIR MRI in Amyotrophic Lateral Sclerosis

por Fabes, Jeremy, Matthews, Lucy, Filippini, Nicola, Talbot, Kevin, Jenkinson, Mark, Turner, Martin R.
Publicado 2017

TDP-43 expression in mouse models of amyotrophic lateral sclerosis and spinal muscular atrophy

por Turner, Bradley J, Bäumer, Dirk, Parkinson, Nicholas J, Scaber, Jakub, Ansorge, Olaf, Talbot, Kevin
Publicado 2008

SMA-EUROPE workshop report: opportunities and challenges in developing clinical trials for spinal muscular atrophy in Europe

por Kayadjanian, Nathalie, Burghes, Arthur, Finkel, Richard S, Mercuri, Eugenio, Rouault, Francoise, Schwersenz, Inge, Talbot, Kevin
Publicado 2013

Myelin imaging in amyotrophic and primary lateral sclerosis

por Kolind, Shannon, Sharma, Rakesh, Knight, Steven, Johansen-Berg, Heidi, Talbot, Kevin, Turner, Martin R.
Publicado 2013

Hyperexcitability in young iPSC-derived C9ORF72 mutant motor neurons is associated with increased intracellular calcium release

por Burley, Sarah, Beccano-Kelly, Dayne A., Talbot, Kevin, Llana, Oscar Cordero, Wade-Martins, Richard
Publicado 2022

Progressive hemiparesis (Mills syndrome) with aphasia in amyotrophic lateral sclerosis

por Bäumer, Dirk, Butterworth, Richard, Menke, Ricarda A.L., Talbot, Kevin, Hofer, Monika, Turner, Martin R.
Publicado 2014